Providing support and services for people and families living with ALS in Ontario.
Funding high-quality research that offers the most promise to slow down ALS or even stop it.
Advocating for policy that will have a meaningful impact on people living with ALS today and in the future.
Many individuals and organizations generously give their time to create and host fundraising even...
An interdisciplinary Canadian team headed by Dr. Gary Armstrong of The Neuro (Montreal Neurological Institute-Hospital) is poised to explore how a recently linked pair of genes contribute to the onset of ALS. In 2014, mutations in a gene called CHCHD10...
August 31, 2021 - Today Amylyx announced that Health Canada has accepted its New Drug Submission (NDS) for AMX0035. This step triggers a thorough regulatory review of the therapy, which...
Read the update